Catalyst
Slingshot members are tracking this event:
Kite Pharma (KITE) to launch Phase 1 studies ZUMA-3 and ZUMA-4 Assessing KTE-C19 in Patients with Acute Lymphoblastic Leukemia
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| KITE |
|
|
||||
Additional Information
ZUMA-4 will study pediatric acute lymphoblastic leukemia
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 12, 2015
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Acute Lymphoblastic Leukemia, Phase 1 Clinical Study, Kte-c19, Zuma-3, Zuma-4
